Anthracycline-based combined chemotherapy in the mouse model

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 32, Issue 2, 2007, Pages 101-108

  Popovic, Mira ^a   Kolarovic, J ^b   Mikov, M ^c,d   Trivic, S ^a   Kaurinovic, B ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b Institute for Child and Youth Health Care   (Serbia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Animal model mice; Antineoplastic anthracycline agents; Liver

Indexed keywords

ACETYLCYSTEINE; CATALASE; CHOLIC ACID DERIVATIVE; DOXORUBICIN; GLUTATHIONE PEROXIDASE; MONOKETOCHOLIC ACID; PEROXIDASE; PREDNISOLONE; SELENITE; SELENIUM; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VINCRISTINE; XANTHINE OXIDASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; LIPID PEROXIDATION; MOUSE; NONHUMAN;

EID: 34547605363     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190998     Document Type: Article

References (36)

1. Maccari F., Ramacci M.T. (1981): Antagonism of doxorubicin cardiotoxicity by carnitine is specific of the L-diastereoisomer. Biomedicine, 35, 65-67.
2. Pommier Y., Schwatrz R.E., Zelling L.A., Kohn K.W. (1985): Effects of PNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei. Biochemistry, 24, 6406-6410.
3. Massart C., Barbet R., Genetet N., Gibassier J. (2004): Doxorubicin Induces Fas-Mediated Apoptosis in Human Thyroid Carcinoma Cells. Thyroid, 14, 263-270.
4. Wu X.X., Kakehi Y., Mizutani Y., Kamoto T., Kinoshita H., Isogawa Y., Terachi T., Ogawa O. (2002): Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer. Int. J. Oncol., 20, 949-954.
5. Wu X.X., Mizutani Y., Kakehi Y., Yoshida O., Ogawa O. (2000): Enhancement of Fas-mediated Apoptosis in Renal Cell Carcinoma Cells by Adriamycin. Cancer Res., 60, 2912-2918.
6. Müller I., Jenner A., Bruchelt G., Niethammer D., Halliwell B. (1997): Effect of Concentration on the Cytotoxic Mechanism of Doxorubicin - Apoptosis and Oxidative DNA Damage. Biochem. Biophys. Res. Commun., 230, 254-257.
7. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. (1993): p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967.
8. Smets L.A.(1994): Programmed cell death (apoptosis) and response to anti-cancer drugs. Anti-Cancer Drugs, 5, 3-9.
9. Fisher D.E. (1994): Apoptosis in cancer therapy: Crossing the threshold. Cell, 78, 539-542.
10. Abraham R., Basser R.L., Green M.D. (1996): A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy. Drug Safety, 15, 406-429.
11. Kalender Y., Yel M., Kalender S. (2005): Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats: The effects of vitamin E and catechin. Toxicology, 209, 39-45.
12. Dargel R. (1992): Lipid peroxidation - a common pathogenetic mechanism? Exp. Toxicol. Pathol., 44, 169-181.
13. Bordoni A., Biagi PL., Hrelia S.(1999): The impairment of essential fatty acid metabolism as a key factor in doxorubicin-induced damage in cultured rat cardiomyocytes. Biochim. Biophys. Acta, 1440, 100-106.
14. Nakata K., Kawase M., Ogino S., Kinoshita C., Murata H., Sakaue T., Ogata, K., Ohmori, S. (1996): Effects of age on levels of cysteine, glutathione and related enzyme activities in livers of mice and rats and an attempt to replenish hepatic glutathione level of mouse with cysteine derivatives. Mech. Ageing Dev., 90, 195-207.
15. Nakata K., Kawase M., Ogino S., Kinoshita C., Murata H., Sakaue T., Ogata, K., Ohmori, S. (1996): Effects of age on levels of cysteine, glutathione and related enzyme activities in livers of mice and rats and an attempt to replenish hepatic glutathione level of mouse with cysteine derivatives. Mech. Ageing Dev., 90, 195-207.
16. Nakata K., Kawase M., Ogino S., Kinoshita C., Murata H., Sakaue T., Ogata, K., Ohmori, S. (1996): Effects of age on levels of cysteine, glutathione and related enzyme activities in livers of mice and rats and an attempt to replenish hepatic glutathione level of mouse with cysteine derivatives. Mech. Ageing Dev., 90, 195-207.
17. De Flora S., Bennicelli C., Camoirano A., Serra D., Romano M., Rossi G.A., Morelli A., De Flora A. (1985): In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds. Carcinogenesis, 6, 1735-1745.
18. Issels R.D., Nagele A., Eckert K.G., Wllmanns W. (1988): Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine. Biochem. Pharmacol., 37, 881-888.
19. Villani F., Galimberti M., Favalli L., Rozza A., Lanza E., Poggi P. (1991): The prevention of the myocardial toxicity of doxorubicin with superoxide dismutase. G. Ital. Cardiol., 21, 633-641.
20. Armstrong M.J., Carey M.C.(1982): The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities. J. Lipid Res., 23, 70-80.
21. Carey M.C., Small D.M.(1969): Micellar properties of dihydroxy and trihydroxy bile salts: Effects of counterion and temperature. J. Colloid Interf. Sci., 31, 382-396.
22. Dobbins J.W., Binder H.J. (1976): Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology, 70, 1096-1100.
23. Schrappe M., Reiter A., Ludwig W.D., et al.(2000): Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood, 95, 3310-3322.
24. Clarke CGE (1980): Isolation and identification of drugs. The Pharmaceutical Press, London, UK.
25. Buege A.J., Aust D.S. (1988): Microsomal lipid peroxidation. In: Fleischer S., Parker L., Eds. Methods in Enzymology. Academic Press, New York, USA.
26. Simon L. M., Fatrai Z., Jonos D. E., Matkovics B. (1974): Study of metabolism enzymes during the development of Phaseolus vulgaris. Biochem. Physiol. Pflanzen., 166, 387-392.
27. Beers R.F.J., Sizer J.W.(1952): A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase . J. Biol. Chem, 195, 133-140.
28. Chiu D.T.Y., Stults F.H., Tappel A.L (1976): Purification and properties of rat lung soluble glutathione peroxidase. Biochim. Biophys. Acta, 445, 558-566.
29. Bergmeyer, U.H. (1970): Methoden Der Enzymatischen Analyze. Weinheim: Verlag Chemie.
30. Li T., Danelisen I., Singal P.K (2002): Early changes in myocardial antioxidant enzymes in rats treated with adriamycin. Mol. Cell. Biochem., 232, 19-26.
31. Jang Y.M., Kendaiah S., Drew B., Phillips T., Selman C., Julian D., Leeuwenburgh C. (2004): Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett., 577, 483-490.
32. Pawlowska J., Priebe W., Paine M., Wolf C.R., Borowski E., Tarasiuk J. (2004): The Ability of New Sugar-Modified Derivatives of Antitumor Anthracycline, Daunorubicin, to Stimulate NAD(P)H Oxidation in Different Cellular Oxidoreductase Systems: NADH Dehydrogenase, NADPH Cytochrome P450 Reductase, and Xanthine Oxidase. Oncol. Res., 14, 469-474.
33. Kang Y.J., Sun X.H., Chen Y., Zhou Z.X. (2002): Inhibition of Doxorubicin Chronic Toxicity in Catalase-Overexpressing Transgenic Mouse Hearts. Chem. Res. Toxicol., 15, 1-6.
34. El-Missiry M.A., Othman A.I., Amer M.A., Abd El-Aziz M.A. (2001): Attenuation of the acute adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-mercaptopropionyl) glycine in rats. Free Radical Res., 35, 575-581.
35. Den Hartog G.J., Haenen G.R., Vegt E., van der Vijgh W.J., Bast A. (2003): Superoxide dismutase: the balance between prevention and induction of oxidative damage. Chem.-Biol. Interact., 145, 33-39.
36. Liu, Q.Y., Tan, B.K. (2003): Relationship between antioxidant activities and doxorubicin-induced lipid peroxidation in P388 tumour cells and heart and liver in mice. Clin. Exp. Pharmacol. Physiol., 30, 185-188.